Daniel M Schmitt insider trades

Open-market stock purchases and sales by Daniel M Schmitt, President, CEO and Director at Actuate Therapeutics, Inc, from SEC Form 4 filings since Aug 14, 2024.

Recent trades

DateStockTradeValue
Apr 1, 2026ACTU Actuate Therapeutics, IncBought (not open market)—
Feb 13, 2026ACTU Actuate Therapeutics, IncBought (not open market)—
Feb 13, 2026ACTU Actuate Therapeutics, IncSold (not open market)$528K

Companies traded

  • ACTU Actuate Therapeutics, Inc: other filings, last Apr 1, 2026

Get free alerts when Daniel M Schmitt files a new trade →